Validation of the 6-Minute Walk in Patients With Pulmonary Arterial Hypertension
- 17 July 2012
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 126 (3) , 258-260
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension TrialsCirculation, 2012
- The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2011
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Systematic review of trials using vasodilators in pulmonary arterial hypertension: Why a new approach is neededAmerican Heart Journal, 2010
- A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodologyAmerican Heart Journal, 2007
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJACC, 2002
- Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise TestingAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments1998
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992